Accro Bioscience
Business Services · China · 11-50 Employees
View Company Info for Free
Overview
Headquarters
Suzhou, Jiangsu, ChinaPhone Number
+86 51262626021Website
accropeutics.comRevenue
$19.4 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1
About Accro Bioscience
Accro Bioscience was established in late 2017 and raised exclusive series A investment from Morningside Ventures. The company's research centers on the molecular mechanism of regulated cell death such as necroptosis, pyroptosis, and ferroptosis, which are associated with major human diseases.Explore more
Accro Bioscience Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Accro Bioscience your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Congratulate Masked Content for being promoted to Masked Content at Accro Bioscience
Website visits: Recent activity has been detected on your website
Funding: Get notified immidiatlly once Accro Bioscience has new funding data
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Accro Bioscience, which may be a good buyer, showed buying intent in Masked Content Topic
Check if Accro Bioscience has recently received funding, and reach out quickly before it becomes old news!
Check out if Accro Bioscience is spiking on competitors!
Product Launch: Get notified when Accro Bioscience launches new products
Earning: See what the market has to say on Accro Bioscience recently announced quarterly report
Click to see if Accro Bioscience had a recent Job posting/layoffs
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 3 more new buyers
Company Profile Activity
Activity Insights
Accro Bioscience is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Accro Bioscience is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Accro Bioscience.
Accro Bioscience financials insights
Gather financial insights about Accro Bioscience, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2025
Series B
$12M
2026
Series C
$50M
Most Recent Scoops
Funding
Funding
Project
Laboratory Operations, Medical Research, Clinical Operations
Funding
Funding
Funding
Accro Bioscience News & Media
Accropeutics Secured $12 Million in Series B Plus Financing
Approximately $12 million additional financing led by Shenzhen Capital Group (SCGC), with participation from existing investor Morningside Ventures, and new investors Leader Venture Investment (SZTI) and Hefei Sci-Tec Venture Capital (HFST). Cash runway extended into the second half of 2026 NEW YORK and SUZHOU, China, March 14, 2025 /PRNewswire/ -- Accropeutics Inc. (Accropeutics), a clinical-stage biotechnology company pioneering the development of novel therapeutics that target molecular mecha
Read more news
Top Business Services Companies
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Accro Bioscience
Sign Up For FreeTo access detailed company insights
Accro Bioscience was established in late 2017 and raised exclusive series A investment from Morningside Ventures. The company's research centers on the molecular mechanism of regulated cell death such as necroptosis, pyroptosis, and ferroptosis, which are associated with major human diseases.... Read More
